 AUSTIN, Texas, Dec. 18, 2020 GLOBE NEWSWIRE -- Lumo s Pharma, Inc. NASDAQ:LUMO, a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the company will participate in the virtual H.C. Wainwright BioConnect 2021 Conference to be held January 11-14, 2021. 